Elixinol Wellness

Elixinol Wellness EBITDA per Employee

EBITDA per Employee of Elixinol Wellness (EXL.AX) as of Oct 16, 2026.

EBITDA per Employee

-AUD

Last updated:

EBITDA per Employee of Elixinol Wellness is 2026 - AUD. EBITDA per Employee of Elixinol Wellness was 2025 - AUD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Elixinol Wellness Stock analysis

What does Elixinol Wellness do? Elixinol Wellness Ltd, trading under the ticker symbol EXL.AX and identified by the ISIN AU000000EXL4, is a Sydney-based entity operating within the Consumer Staples sector, specifically in the consumer products industry. The company officially entered the public markets through an initial public offering on January 8, 2018. Its primary business activity involves the sale of nutraceutical and related hemp products, positioning itself as a significant player in the global hemp-derived wellness market. The corporate headquarters are located in Sydney, New South Wales, serving as the central hub for its international operations and strategic direction. The firm’s commercial activities are broadly categorized into marketing and selling hemp-derived nutraceutical, cosmetic, and food products under two core brands: Elixinol and Hemp Foods Australia. The company’s operational footprint is extensive, covering various key markets across the globe. In the Americas, the company operates through a presence in Colorado, United States, where it markets and sells Elixinol branded hemp and other plant-derived nutraceutical and skincare products. This North American segment represents a crucial part of its consumer-facing strategy. In Australia, the company’s operations include Hemp Foods Australia, which functions as a wholesaler, retailer, manufacturer, and exporter of both bulk and branded raw materials as well as finished products. This dual-brand approach allows the company to cater to different segments of the market, from raw material supply to direct consumer goods. Internationally, the Elixinol brand is distributed through a network of distribution and trademark licensing agreements. This model is utilized in markets including the United Kingdom, South Africa, Japan, Brazil, and Mexico, with approvals pending for Malaysia. These licensing and distribution arrangements enable the company to expand its reach without necessarily establishing direct operational subsidiaries in every jurisdiction. Additionally, the company serves the Rest of World market by distributing Elixinol branded hemp-derived products through various distributors. This multi-faceted approach to global distribution allows Elixinol Wellness Ltd to leverage local partnerships while maintaining brand consistency. The company’s website, https://www.elixinolwellness.com/site/content/, serves as a central point for information regarding its products and corporate updates. By combining direct operations in key markets with licensing and distribution agreements elsewhere, Elixinol Wellness Ltd aims to capitalize on the growing demand for hemp-based wellness solutions across diverse geographical regions. Elixinol Wellness is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Elixinol Wellness stock

On Eulerpool you can find the complete historical development of EBITDA per Employee Elixinol Wellness since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Elixinol Wellness historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Elixinol Wellness

All Key Metrics — Elixinol Wellness